2024-05-06 | EyePoint Pharmaceuticals, Inc. EYPT | 10 percent owner | 850,000 1.8064% | $11.86 | $10.08M | -4.24% | ||
2024-04-18 | EyePoint Pharmaceuticals, Inc. EYPT | 10 percent owner | 581,765 1.2029% | $18.03 | $10.49M | -35.22% | ||
2024-04-01 | Sale | Immuneering Corporation IMRX | 10 percent owner | 400,000 1.4407% | $2.90 | $1.16M | -44% | |
2024-03-15 | Sale | Immuneering Corporation IMRX | 10 percent owner | 400,000 1.5312% | $2.14 | $856,400 | -18.32% | |
2024-03-14 | Sale | Immuneering Corporation IMRX | 10 percent owner | 509,091 1.0954% | $3.72 | $1.89M | -46.21% | |
2024-01-11 | EyePoint Pharmaceuticals, Inc. EYPT | 10 percent owner | 750,000 2.0594% | $19.75 | $14.81M | +2.4% | ||
2024-01-09 | EyePoint Pharmaceuticals, Inc. EYPT | 10 percent owner | 105,000 0.2958% | $21.32 | $2.24M | -3.03% | ||
2023-12-08 | EyePoint Pharmaceuticals, Inc. EYPT | 10 percent owner | 588,235 1.4847% | $17.00 | $10M | +9.04% | ||
2023-12-04 | EyePoint Pharmaceuticals, Inc. EYPT | 10 percent owner | 1.92M 6.3418% | $21.82 | $41.87M | +6.41% | ||
2021-10-25 | Ventyx Biosciences, Inc. VTYX | 1.25M 8.2073% | $16.00 | $20M | -16.24% | |||
2021-10-13 | Pyxis Oncology, Inc. PYXS | 450,000 1.9034% | $16.00 | $7.2M | -70.72% | |||
2021-09-17 | Tyra Biosciences, Inc. TYRA | 625,000 5.4808% | $16.00 | $10M | -43.6% | |||
2021-08-03 | Immuneering Corporation IMRX | 550,000 2.3534% | $15.00 | $8.25M | -47.84% | |||
2021-07-02 | Aerovate Therapeutics, Inc. AVTE | 1M 2.9395% | $14.00 | $14M | -34% | |||
2021-06-29 | Elevation Oncology, Inc. ELEV | 250,000 30.0099% | $16.00 | $4M | -56% | |||
2021-06-28 | Monte Rosa Therapeutics, Inc. GLUE | 600,000 11.7588% | $19.00 | $11.4M | -7.95% | |||
2021-06-21 | Verve Therapeutics, Inc. VERV | 550,000 3.5535% | $19.00 | $10.45M | -7.41% | |||
2021-03-30 | Design Therapeutics, Inc. DSGN | 750,000 2.8822% | $20.00 | $15M | -40.99% | |||
2020-12-18 | BioAtla, Inc. BCAB | 1.6M 2.4444% | $18.00 | $28.8M | +17.46% | |||
2020-11-23 | Olema Pharmaceuticals, Inc. OLMA | 850,000 1.5181% | $19.00 | $16.15M | -44.3% |